Related references
Note: Only part of the references are listed.Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease
Clement Mennetrey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice
Dirk-Jan van Beek et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
MEN1 Surveillance Guidelines: Time to (Re)Think?
Paul J. Newey et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2022)
Health-Related Quality of Life in Patients with Multiple Endocrine Neoplasia Type 1
Rachel S. Van Leeuwaarde et al.
NEUROENDOCRINOLOGY (2021)
Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome - An International Consensus Statement
Bruno Niederle et al.
NEUROENDOCRINOLOGY (2021)
Clinical aspects of multiple endocrine neoplasia type 1
Abdallah Al-Salameh et al.
NATURE REVIEWS ENDOCRINOLOGY (2021)
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2021)
Variants and Pitfalls of PET/CT in Neuroendocrine Tumors
Alessio Imperiale et al.
SEMINARS IN NUCLEAR MEDICINE (2021)
The Impact of 68Gallium DOTA PET/CT in Managing Patients With Sporadic and Familial Pancreatic Neuroendocrine Tumours
Daniel J. Cuthbertson et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Comparison of68Ga-DOTA-NaI3-Octreotide/tyr3-octreotate positron emission tomography/computed tomography and contrast-enhanced computed tomography in localization of tumors in multiple endocrine neoplasia 1 syndrome
Virendra A. Patil et al.
WORLD JOURNAL OF NUCLEAR MEDICINE (2020)
Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT
Susanna Majala et al.
EJNMMI RESEARCH (2019)
Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA
Murat Fani Bozkurt et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging
Anders Sundin et al.
NEUROENDOCRINOLOGY (2017)
Limited Value of Ga-68-DOTATOC-PET-CT in Routine Screening of Patients with Multiple Endocrine Neoplasia Type 1
Max B. Albers et al.
WORLD JOURNAL OF SURGERY (2017)
Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients
Wei Qiu et al.
CLINICAL ENDOCRINOLOGY (2016)
Evaluation of 68Ga-DOTA-TOC PET/CT for the detection of duodenopancreatic neuroendocrine tumors in patients with MEN1
Clement Morgat et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors
M. Falconi et al.
NEUROENDOCRINOLOGY (2016)
Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies
Tetsuhide Ito et al.
INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY (2016)
Role of 68Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1)
Secondo Lastoria et al.
ENDOCRINE (2016)
Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1
Samira M. Sadowski et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
The assessment of time-of-flight on image quality and quantification with reduced administered activity and scan times in 18F-FDG PET
Ian S. Armstrong et al.
NUCLEAR MEDICINE COMMUNICATIONS (2015)
Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1
Benzon M. Dy et al.
AMERICAN JOURNAL OF SURGERY (2014)
Low Accuracy of Tumor Markers for Diagnosing Pancreatic Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1 Patients
Joanne M. de Laat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study Comparison of 106 MEN1/Zollinger-Ellison Syndrome Patients With 1613 Literature MEN1 Patients With or Without Pancreatic Endocrine Tumors
Tetsuhide Ito et al.
MEDICINE (2013)
A national survey on radiation dose in CT in The Netherlands
A. J. van der Molen et al.
INSIGHTS INTO IMAGING (2013)
Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
Vera Froeling et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Clinical Practice Guidelines for Multiple Endocrine Neoplasia Type 1 (MEN1)
Rajesh V. Thakker et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Risk Factors and Causes of Death in MEN1 Disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) Cohort Study Among 758 Patients
Pierre Goudet et al.
WORLD JOURNAL OF SURGERY (2010)
Asymptomatic Children with Multiple Endocrine Neoplasia Type 1 Mutations May Harbor Nonfunctioning Pancreatic Neuroendocrine Tumors
Paul J. Newey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Imaging of neuroendocrine tumours (CT/MR/US)
Andrea G. Rockall et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2007)